Acorai logo

Acorai

The new standard in heart failure management

25 employees · est. 2019 · Helsingborg, Sweden

VS
BMEYE logo

BMEYE

Pioneering non-invasive cardiovascular monitoring with advanced finger arterial pressure and cardiac output technologies for global healthcare.

est. 2005

BMEYE is the older company (2019 vs 2005).

Side-by-Side Comparison

Acorai BMEYE
Founded
2019 2005 older
Headquarters
Helsingborg, Sweden Not tracked yet
Employees
25 Not tracked yet
Industry
Health Care, Medical Devices, Pharmaceutical Biotechnology, Health Care, Medical Devices
Funding Stage
Non Equity Assistance Series B
Total Funding
$47.75M $6.00M
Funding Rounds
8 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
MedTech, Cardiology, Heart Failure Management, Non-invasive Monitoring, Medical Device, FDA Breakthrough Device, Clinical Validation, Regulatory Pathway, Commercialization, Intracardiac Pressure Monitoring, Digital Health, Cardiovascular, Clinical Advisors Cardiovascular Monitoring, Non-invasive Monitoring, Finger Arterial Pressure, Cardiac Output Technologies, Biomedical Engineering, Innovative Medical Devices, Hemodynamics Monitoring, Cardiology Technology, Anesthesiology Equipment, Physiological Measurement, Global Healthcare Solutions
Website
acorai.com bmeye.com
Acorai logo

About Acorai

Acorai is a progressive startup revolutionizing heart failure management with its innovative non-invasive intracardiac pressure monitoring (ICPM) device. The company's slogan "The new standard in heart failure management" captures its commitment to improving patient outcomes. By leveraging machine l...

BMEYE logo

About BMEYE

**BMEYE** is a Netherlands-based non-invasive cardiovascular monitoring company that has been pioneering advanced finger arterial pressure and cardiac output technologies for global healthcare since **2005**. The company's product offerings include **Finapres**, **Portapres**, **Finometer**, **BeatS...

We will tell you when either one moves

BounceWatch watches Acorai and BMEYE for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Acorai and BMEYE — by email.

Frequently Asked Questions

Acorai — The new standard in heart failure management. BMEYE — Pioneering non-invasive cardiovascular monitoring with advanced finger arterial pressure and cardiac output technologies for global healthcare.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Acorai has raised $47.75M while BMEYE has raised $6.00M.
Acorai and BMEYE operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Acorai with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Acorai on 11 Sep 2024, and BMEYE on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy